Song Zhiwei, Pre-recordSenior Principal Scientist at A*STAR
Dr. Song Zhiwei obtained his Ph.D. degree in Biochemistry from the University of Michigan where he studied protein glycosylation in cancer cells and their interactions with plant lectins. His post-doc work was completed in the Biology Department at Massachusetts Institute of Technology (MIT) where he studied genetic control of apoptosis. He then worked at the Biotechnology Process Engineering Center (BPEC) at MIT, before moving to Singapore in 2002. Currently, Dr. Song is a Senior Principal Scientist at the Bioprocessing Technology Institute (BTI) of A*STAR. His lab has been focused on protein glycosylation, glycoengineering of CHO cells with different genome editing techniques, and production of antibodies with these glycosylation mutants for in vitro and in vivo characterizations.